WallStreetZenWallStreetZen

NYSE: QGEN
Qiagen Nv Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Qiagen Nv earnings were $373.4M for the trailing 12 months ending Jun 30, 2025, with 466.7% growth year over year. The latest QGEN earnings report on Jun 30, 2025 announced Q2 2025 earnings of $96.3M, up 6.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, QGEN reported annual earnings of $83.6M, with -75.5% growth. The next QGEN earnings date is Nov 5, 2025.

QGEN past earnings growth

How has QGEN's earnings growth performed historically?

Company
466.67%
Industry
10.57%
Market
34.36%
QGEN's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
QGEN's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
QGEN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

QGEN earnings history

Current Revenue
$2.0B
Current Earnings
$373.4M
Current Profit Margin
18.3%
QGEN's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

QGEN Return on Equity

Current Company
10.7%
Current Industry
-3.9%
Current Market
30.7%
QGEN's Return on Equity (10.7%)... subscribe to Premium to read more.
High Return on Equity Performance

QGEN undefined

Current Company
6.4%
Current Industry
7.7%
QGEN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when QGEN announces earnings.

QGEN undefined

Current Company
11.21%
Current Industry
15.7%
QGEN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

QGEN vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
QGEN$715.14M$373.39M+100.86%$1.70
RVTY$799.33M$285.20M-2.29%$2.36
EXAS-$731.82M-$1.01BN/A-$5.46
CAIN/AN/AN/AN/A
CRL$526.23M-$69.23MN/A-$1.29
View Top Diagnostic & Research Stocks

QGEN earnings dates

Next earnings date
Nov 5, 2025

Qiagen Nv Earnings Reports & History FAQ

What were Qiagen Nv's earnings last quarter?

On QGEN's earnings call on Invalid Date, Qiagen Nv (NYSE: QGEN) reported Q2 2025 earnings per share (EPS) of $0.44, up 153.01% year over year. Total QGEN earnings for the quarter were $96.25 million. In the same quarter last year, Qiagen Nv's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Qiagen Nv stock.

When does Qiagen Nv report earnings?

The next QGEN earnings date is Invalid Date. Add QGEN to your watchlist to be reminded of Qiagen Nv's next earnings date.

Is Qiagen Nv profitable or losing money?

As of the last Qiagen Nv earnings report, Qiagen Nv is currently profitable. Qiagen Nv's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $373.39 million, a 413.63% increase year over year.

What was QGEN's earnings growth in the past year?

As of Qiagen Nv's earnings date in Invalid Date, Qiagen Nv's earnings has grown 466.67% year over year. This is 456.1 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 10.57%. QGEN earnings in the past year totalled $373.39 million.

What are Qiagen Nv's earnings expectations?

The current EPS estimate for Qiagen Nv's earnings report in Invalid Date is $0.50.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.